2202: GLP‑1 Gold Rush: MedPal AI’s CEO on Turning a £45k Deal into a £100bn Opportunity cover art

2202: GLP‑1 Gold Rush: MedPal AI’s CEO on Turning a £45k Deal into a £100bn Opportunity

2202: GLP‑1 Gold Rush: MedPal AI’s CEO on Turning a £45k Deal into a £100bn Opportunity

Listen for free

View show details

About this listen

 MedPal AI has just acquired a licensed online pharmacy and raised £550k to support its next big move: entering the fast-growing GLP‑1 weight-loss market. With drugs like Ozempic and Mounjaro in high demand — and online prescribing facing tighter regulation — MedPal is combining AI health coaching with compliant, NHS-linked pharmacy fulfilment. CEO Jason Drummond joins Vox Markets to break down the deal, the strategy, and what’s next.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.